Top conditions
Top treatments
Parent organization
This site is a part of M3 Wake Research
Data sourced from clinicaltrials.gov
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Clinical trials
Research sites
Resources
Legal